Brazil antitrust regulator Cade’s superintendence approved the deal without restrictions, according to official gazette and Cade’s website.
- NOTE:
Brazil Regulator Seeks More Information on Hypera-Sanofi Deal - NOTE:
Sanofi to Sell Eight Brands to Hypera Pharma in Latin America - NOTE: Decisions made by Cade’s superintendence can be reassessed on court’s floor if board members consider that a deeper analysis of an operation is needed
Original Story:
To contact the translator on this story:
Reporter on the original story:
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.